GLYCOLYTIC REPROGRAMMING FUELS MYELOID CELL-DRIVEN HYPERCOAGULABILITY
A. M. Rehill, G. Leon, S. McCluskey…·R. J. Preston
This study shows inflammation-induced glycolytic reprogramming in myeloid cells drives hypercoagulability and antifibrinolytic activity, with potential therapeutic implications.